Edge Rankings

Eiger BioPharmaceuticals Inc Stock Price, Quotes and Forecasts | OTC:EIGRQ | Benzinga

Q: What sector and industry does Eiger BioPharmaceuticals Inc (EIGRQ) operate in?

Eiger BioPharmaceuticals Inc is in the Health Care sector and Biotechnology industry. They are listed on the OTC.

Explore Eiger BioPharmaceuticals Inc stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EIGRQ.

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	1.61 - 16.00
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	13.58

Recent News

Why Is Small Cap Amylyx Pharmaceuticals Stock Trading Higher On Wednesday?

Amylyx Pharmaceuticals acquired avexitide from Eiger BioPharmaceuticals Inc. for $35.1 million. Avexitide, a GLP-1 receptor antagonist, ready for Phase 3 trial for post-bariatric hypoglycemia and congenital hyperinsulinism.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	1.61 - 16.00
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	13.58

About Eiger BioPharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Eiger BioPharmaceuticals Inc (EIGRQ) stock?

You can purchase shares of Eiger BioPharmaceuticals Inc (OTC:EIGRQ) through any online brokerage.

View our list of the best stock brokerages

Who are Eiger BioPharmaceuticals Inc (EIGRQ) competitors?

There are no as such competitors for Eiger BioPharmaceuticals Inc.

What is the forecast, or price target, for Eiger BioPharmaceuticals Inc (EIGRQ) stock?

There is no analysis for Eiger BioPharmaceuticals Inc to provide a consensus price target.

What is the current price for Eiger BioPharmaceuticals Inc (EIGRQ)?

The stock price for Eiger BioPharmaceuticals Inc (OTC: EIGRQ) is $8.5 last updated September 27, 2024 at 11:27 AM EDT.

Does Eiger BioPharmaceuticals Inc (EIGRQ) pay a dividend?

There are no upcoming dividends for Eiger BioPharmaceuticals Inc.

When is Eiger BioPharmaceuticals Inc (OTC:EIGRQ) reporting earnings?

Eiger BioPharmaceuticals Inc does not have any upcoming earnings scheduled.

Is Eiger BioPharmaceuticals Inc (EIGRQ) going to split?

There is no upcoming split for Eiger BioPharmaceuticals Inc.

What sector and industry does Eiger BioPharmaceuticals Inc (EIGRQ) operate in?

Eiger BioPharmaceuticals Inc is in the Health Care sector and Biotechnology industry. They are listed on the OTC.

Comments

Eiger BioPharmaceuticals Inc Stock Price, Quotes and Forecasts

Eiger BioPharmaceuticals Inc (EIGRQ) Forecast